Biocryst Pharmaceuticals (BCRX) Gross Profit (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Gross Profit of $214.41 million for Q2 2026, up 33.5% from $160.56 million a year earlier and up 42.0% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Gross Profit (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Biocryst Pharmaceuticals was $919.69 million, up 70.0% year-over-year; for FY2025, it came in at $855.76 million, up 95.2% from FY2024.
- Annual Gross Profit has increased for five consecutive years, with a five-year compound annual growth rate of 120.9% (FY2020 to FY2025).
- In prior years, Biocryst Pharmaceuticals' Gross Profit was $438.44 million in FY2024 (+34.1%), $326.93 million in FY2023 (+23.6%), $264.42 million in FY2022 (+76.3%) and $149.94 million in FY2021 (+822.0%).
- Quarterly Gross Profit has run from a low of $40.4 million in Q3 2021 to a high of $397.03 million in Q4 2025 over five years.
- On a year-over-year basis, Gross Profit has increased in each of the last 18 quarters, with growth averaging 58.5% over the last eight quarters.
- Over the past five years, the year-over-year growth in Gross Profit ranged from 7.1% (Q1 2026) to 781.2% (Q3 2021).
- According to Business Quant data, Gross Profit for the three prior quarters was $151.04 million (Q1 2026), $397.03 million (Q4 2025) and $157.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 214.41 Mn |
| Mar 31, 2026 | 151.04 Mn |
| Dec 31, 2025 | 397.03 Mn |
| Sep 30, 2025 | 157.21 Mn |
| Jun 30, 2025 | 160.56 Mn |
| Mar 31, 2025 | 140.97 Mn |
| Dec 31, 2024 | 125.44 Mn |
| Sep 30, 2024 | 113.87 Mn |
| Jun 30, 2024 | 107.63 Mn |
| Mar 31, 2024 | 91.50 Mn |
| Dec 31, 2023 | 91.84 Mn |
| Sep 30, 2023 | 85.64 Mn |
| Jun 30, 2023 | 81.60 Mn |
| Mar 31, 2023 | 67.85 Mn |
| Dec 31, 2022 | 77.16 Mn |
| Sep 30, 2022 | 72.28 Mn |
| Jun 30, 2022 | 65.29 Mn |
| Mar 31, 2022 | 49.69 Mn |
| Dec 31, 2021 | 46.74 Mn |
| Sep 30, 2021 | 40.40 Mn |
API Access
Biocryst Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();